Sarah L. Opitz - Concepedia

Author

Sarah L. Opitz

Also Known As

Sarah L. Opitz, Sarah Opitz

Publications

986

Citations

H-Index

Concepts

All Affiliations

Sarah L. Opitz is an author at Harvard University specializing in cancer research, drug resistance, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	22
2	Medicine	1	1	22
3	Pharmacology	1	1	22
4	Drug Discovery	1	1	22
5	Drug Resistance	1	1	22

Sarah L. Opitz

Publications

984

Citations

H-Index

Page 1

	Year	Citations
LIF/STAT3 Signaling Fails to Maintain Self‐Renewal of Human Embryonic Stem Cells Laurence Dahéron, Sarah L. Opitz, Holm Zaehres, Stem Cells	2004	459
The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling Margit Hagel, Elizabeth George, Ann Kim, Molecular and Cellular Biology	2002	326
Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis Michelle H. Tan, Zhengwu Sun, Sarah L. Opitz, Blood	2004	177
A screen to identify drug resistant variants to target-directed anti-cancer agents Mohammad Azam, Tal Raz, Valentina Nardi, Biological Procedures Online Drug TargetHealth SciencesTumor HeterogeneityMedicineRational Drug Design	2003	22

Page 1